Vol 3, No 1 (2011)

Mol Cell Pharmacol

Table of Contents


Focus on α4β2* and α6β2* nAChRs for Parkinson’s Disease Therapeutics Abstract PDF
Xiomara A Pérez, Maryka Quik 1-6
Molecular Pharmacological Approach Reveals Potential New Strategies to Suppress Androgen Receptor Signaling in Prostate Cancer Abstract PDF
Tetsuo Mashima, Sachiko Okabe, Hiroyuki Seimiya 7-12
STAT3 Inhibition by Microtubule-Targeted Drugs: Dual Molecular Effects of Chemotherapeutic Agents Abstract PDF
Sarah R Walker, Mousumi Chaudhury, David A Frank 13-19

Research Articles

Evaluation of Anticancer Properties of Medicinal Plants from the Indian Sub-Continent Abstract PDF
Akbar Nawab, Mohammad Yunus, Abbas A Mahdi, Sanjay Gupta 21-29


Understanding the Role of the Death Receptor 5/FADD/caspase-8 Death Signaling in Cancer Metastasis Abstract PDF
Shi-Yong Sun 31-34

FDA Corner

FDA Approves Edarbi to Treat High Blood Pressure Abstract PDF
FDA Approves Drug to Reduce Risk of Preterm Birth in At-risk Pregnant Women Abstract PDF
FDA Approves Viibryd to Treat Major Depressive Disorder Abstract PDF
FDA Approves Head Lice Treatment for Children and Adults Abstract PDF

LumiText Publishing, P.O. Box 774, Ellicott City, MD 21041 

Copyright © 2008 LumiText Publishing. All rights reserved.